Key statistics dashboard for Inotiv, Inc. (NOTV). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries in the United States, the Netherlands, and internationally. The company operates through two segments, Discovery and Safety Assessment (DSA) and Research Models and Services (RMS).
Stock Data
| Price | $0.08 |
| Market Cap | $3M |
| Beta | 4.08 |
| Exchange | NASDAQ |
| Country | US |
Valuation Multiples
| P/E Ratio | -0.03 |
| Price / Book | 0.04 |
| P/S | 0.01 |
| P/FCF | -0.20 |
| Dividend Yield | 0.00% |
Profitability
| Gross Margin | 14.70% |
| EBIT Margin | -8.99% |
| EBITDA Margin | 2.01% |
| Operating Margin | -8.87% |
| Net Margin | -17.14% |
Financial Health
| Current Ratio | 0.27 |
| Quick Ratio | 0.19 |
| Cash Ratio | 0.03 |
| Debt / Equity | 6.33 |
| Debt / Assets | 69.44% |
| Interest Coverage | -0.79 |
Per-Share Data
| Revenue per share | 14.64 |
| Book Value per share | 2.22 |
| Cash per share | 0.44 |
| FCF per share | -0.39 |
| Tangible Book Value per share | -6.92 |
| Dividend per share | 0.00 |
Related companies: BDSX · BEAT · BIAF · CELU · FGEN · KZR · QNTM
Explore sector: Healthcare · Medical - Diagnostics & Research
More sections of NOTV: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks